APYX — Apyx Medical Income Statement
0.000.00%
HealthcareSpeculativeSmall CapNeutral
- $88.34m
- $75.53m
- $44.51m
- 48
- 35
- 22
- 27
Annual income statement for Apyx Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16.6 | 28.2 | 27.7 | 48.5 | 44.5 |
Cost of Revenue | |||||
Gross Profit | 10.8 | 19.1 | 17.5 | 33.6 | 29.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 30.9 | 49.1 | 47.8 | 63 | 68.1 |
Operating Profit | -14.3 | -20.9 | -20.1 | -14.4 | -23.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.7 | -19.8 | -19.4 | -14.8 | -22.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.8 | -19.7 | -15.6 | -15.2 | -23.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 62.7 | -19.7 | -11.9 | -15.2 | -23.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 62.7 | -19.7 | -11.9 | -15.2 | -23.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.31 | -0.578 | -0.455 | -0.442 | -0.672 |